Melatonin enhances cisplatin-induced cell death through inhibition of DERL1 in mesenchymal-like CD44high OSCC cells
- PMID: 34551150
- DOI: 10.1111/jop.13242
Melatonin enhances cisplatin-induced cell death through inhibition of DERL1 in mesenchymal-like CD44high OSCC cells
Abstract
Background: Melatonin is a hormone that is primarily produced in the pineal gland and is involved in wide range of biological functions. However, the impact of melatonin on chemotherapy-induced cell death remains to be elucidated in oral squamous cell carcinoma (OSCC) cells. The objective of this study was to clarify the role of melatonin in cisplatin-induced cytotoxicity in CD44high OSCC cells.
Methods: CD44high OSCC cells were cultured on fibronectin-coated hydrogel. A lactate dehydrogenase cytotoxicity assay was performed to evaluate cisplatin-induced cell death. The effect of melatonin on cisplatin-induced cell death and Derlin-1 (DERL1) endoplasmic reticulum membrane protein expression was investigated.
Results: CD44high OSCC cells exhibited mesenchymal-like features when cultured on fibronectin-coated hydrogel. Mesenchymal-like CD44high OSCC cells demonstrated strong resistance to cisplatin-induced cell death compared with epithelial-like CD44high OSCC cells. DERL1 mRNA and DERL1 protein expression levels were significantly higher in mesenchymal-like CD44high cells compared with epithelial-like CD44high cells. Cisplatin-induced cell death was significantly enhanced after DERL1 siRNA knockdown, suggesting that DERL1 is involved in resistance to cisplatin-induced cell death. Melatonin significantly inhibited DERL1 expression and enhanced cisplatin-induced cell death in mesenchymal-like CD44high cells. miR-181c-5p expression was significantly upregulated in the presence of melatonin. Furthermore, melatonin-inhibited DERL1 expression was significantly recovered by miR-181c-5p inhibitor. In addition, melatoninenhanced cisplatin-induced cell death was attenuated by miR-181c-5p inhibitor. These results suggest that melatonin-induced miR-181c-5p enhances cisplatin-induced cell death through inhibition of DERL1 in mesenchymal-like CD44high cells.
Conclusions: Melatonin plays a vital role in promoting cisplatin-induced cytotoxicity in mesenchymal-like CD44high OSCC cells.
Keywords: CD44; DERL1; cell death; melatonin; oral squamous cell carcinoma.
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Effect of melatonin supplementation in combination with neoadjuvant chemotherapy to miR-210 and CD44 expression and clinical response improvement in locally advanced oral squamous cell carcinoma: a randomized controlled trial.J Egypt Natl Canc Inst. 2020 Feb 28;32(1):12. doi: 10.1186/s43046-020-0021-0. J Egypt Natl Canc Inst. 2020. PMID: 32372215 Clinical Trial.
-
MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.J Biomed Sci. 2022 Jun 15;29(1):42. doi: 10.1186/s12929-022-00824-z. J Biomed Sci. 2022. PMID: 35706019 Free PMC article.
-
Effects of miR-224-5p-enhanced downregulation of pannexin-1 on docetaxel-induced apoptosis in amoeboid-like CD44high oral cancer cells.Eur J Oral Sci. 2021 Oct;129(5):e12812. doi: 10.1111/eos.12812. Epub 2021 Jul 8. Eur J Oral Sci. 2021. PMID: 34236115
-
TGF-β1 induces amoeboid-to-mesenchymal transition of CD44high oral squamous cell carcinoma cells via miR-422a downregulation through ERK activation and Cofilin-1 phosphorylation.J Oral Pathol Med. 2021 Feb;50(2):155-164. doi: 10.1111/jop.13113. Epub 2020 Oct 29. J Oral Pathol Med. 2021. PMID: 33107637
-
The role of non-coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential.Cancer Commun (Lond). 2021 Oct;41(10):981-1006. doi: 10.1002/cac2.12194. Epub 2021 Jul 20. Cancer Commun (Lond). 2021. PMID: 34289530 Free PMC article. Review.
Cited by
-
miR-181c-5p/DERL1 pathway controls breast cancer progression mediated by TRAF6-linked K63 ubiquitination of AKT.Cancer Cell Int. 2024 Jun 10;24(1):204. doi: 10.1186/s12935-024-03395-1. Cancer Cell Int. 2024. PMID: 38858669 Free PMC article.
-
Targeting cancer stem cells as a strategy for reducing chemotherapy resistance in head and neck cancers.J Cancer Res Clin Oncol. 2023 Nov;149(14):13417-13435. doi: 10.1007/s00432-023-05136-9. Epub 2023 Jul 15. J Cancer Res Clin Oncol. 2023. PMID: 37453969 Free PMC article. Review.
-
Methods for Overcoming Chemoresistance in Head and Neck Squamous Cell Carcinoma: Keeping the Focus on Cancer Stem Cells, a Systematic Review.Cancers (Basel). 2024 Aug 29;16(17):3004. doi: 10.3390/cancers16173004. Cancers (Basel). 2024. PMID: 39272862 Free PMC article. Review.
-
circFNDC3B Accelerates Vasculature Formation and Metastasis in Oral Squamous Cell Carcinoma.Cancer Res. 2023 May 2;83(9):1459-1475. doi: 10.1158/0008-5472.CAN-22-2585. Cancer Res. 2023. PMID: 36811957 Free PMC article.
References
REFERENCES
-
- Peres MA, Macpherson LMD, Weyant RJ, et al. Oral diseases: a global public health challenge. Lancet. 2019;394:249-260.
-
- Shigeishi H, Biddle A, Gammon L, et al. Elevation in 5-FU-induced apoptosis in head and neck cancer stem cells by a combination of CDHP and GSK3β inhibitors. J Oral Pathol Med. 2015;44:201-207.
-
- Shigeishi H, Yokoyama S, Murodumi H, et al. Effect of hydrogel stiffness on morphology and gene expression pattern of CD44high oral squamous cell carcinoma cells. Int J Clin Exp Pathol. 2019;12:2826-2836.
-
- Schwarz DS, Blower MD. The endoplasmic reticulum: structure, function and response to cellular signaling. Cell Mol Life Sci. 2016;3:79-94.
-
- Kaufman RJ. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev. 1999;13:1211-1233.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous